ALFLO Fundamental Analysis - FLORENTAISE SA

Name: FLORENTAISE SA (ALFLO) Stock
Brand: FLORENTAISE SA
Rating: 2.5 (3 reviews)

Fundamental Rating

ALFLO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 67 industry peers in the Chemicals industry. ALFLO has a bad profitability rating. Also its financial health evaluation is rather negative. ALFLO does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALFLO had negative earnings in the past year.

In the past year ALFLO had a positive cash flow from operations.

ALFLO had positive earnings in 4 of the past 5 years.

Of the past 5 years ALFLO 4 years had a positive operating cash flow.

1.2 Ratios

ALFLO has a Return On Assets (-0.03%) which is comparable to the rest of the industry.

ALFLO has a Return On Equity (-0.08%) which is in line with its industry peers.

ALFLO's Return On Invested Capital of 1.63% is in line compared to the rest of the industry. ALFLO outperforms 42.42% of its industry peers.

		Industry Rank	Sector Rank
ROA	-0.03%
ROE	-0.08%
ROIC	1.63%

ROA(3y)1.39%

ROA(5y)1.89%

ROE(3y)6.19%

ROE(5y)9.6%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 1.94%, ALFLO is doing worse than 60.61% of the companies in the same industry.

In the last couple of years the Operating Margin of ALFLO has declined.

Looking at the Gross Margin, with a value of 48.22%, ALFLO is in the better half of the industry, outperforming 71.21% of the companies in the same industry.

ALFLO's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	1.94%
PM (TTM)	N/A
GM	48.22%

OM growth 3Y-14.25%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.26%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALFLO is destroying value.

Compared to 1 year ago, ALFLO has about the same amount of shares outstanding.

Compared to 5 years ago, ALFLO has about the same amount of shares outstanding.

Compared to 1 year ago, ALFLO has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.75, we must say that ALFLO is in the distress zone and has some risk of bankruptcy.

ALFLO has a Altman-Z score of 0.75. This is amonst the worse of the industry: ALFLO underperforms 80.30% of its industry peers.

A Debt/Equity ratio of 0.73 indicates that ALFLO is somewhat dependend on debt financing.

ALFLO's Debt to Equity ratio of 0.73 is on the low side compared to the rest of the industry. ALFLO is outperformed by 68.18% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.73
Debt/FCF	N/A
Altman-Z	0.75

ROIC/WACC0.34

WACC4.85%

2.3 Liquidity

ALFLO has a Current Ratio of 0.73. This is a bad value and indicates that ALFLO is not financially healthy enough and could expect problems in meeting its short term obligations.

ALFLO's Current ratio of 0.73 is on the low side compared to the rest of the industry. ALFLO is outperformed by 90.91% of its industry peers.

A Quick Ratio of 0.47 indicates that ALFLO may have some problems paying its short term obligations.

ALFLO has a Quick ratio of 0.47. This is amonst the worse of the industry: ALFLO underperforms 92.42% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.73
Quick Ratio	0.47

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALFLO have decreased strongly by -115.82% in the last year.

ALFLO shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.65%.

Measured over the past years, ALFLO shows a small growth in Revenue. The Revenue has been growing by 4.41% on average per year.

EPS 1Y (TTM)-115.82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%1.17%

Revenue 1Y (TTM)23.65%

Revenue growth 3Y4.41%

Revenue growth 5YN/A

Sales Q2Q%21.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALFLO. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

92.42% of the companies in the same industry are more expensive than ALFLO, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	4.6

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALFLO!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

FLORENTAISE SA

EPA:ALFLO (10/24/2025, 7:00:00 PM)

0.6

0 (-0.33%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners92.45%

Ins Owner ChangeN/A

Market Cap4.95M

Revenue(TTM)66.70M

Net Income(TTM)-26000

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0.02

Dividend Growth(5Y)N/A

DP-538.46%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.07
P/FCF	N/A
P/OCF	0.85
P/B	0.15
P/tB	5.83
EV/EBITDA	4.6

EPS(TTM)-0.01

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.45

FCFYN/A

OCF(TTM)0.7

OCFY117.21%

SpS8.08

BVpS3.95

TBVpS0.1

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.03%
ROE	-0.08%
ROCE	2.21%
ROIC	1.63%
ROICexc	1.79%
ROICexgc	4.46%
OM	1.94%
PM (TTM)	N/A
GM	48.22%
FCFM	N/A

ROA(3y)1.39%

ROA(5y)1.89%

ROE(3y)6.19%

ROE(5y)9.6%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3Y1.62%

ROICexgc growth 5YN/A

ROICexc growth 3Y-24.16%

ROICexc growth 5YN/A

OM growth 3Y-14.25%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.26%

GM growth 5YN/A

F-Score6

Asset Turnover0.66

Health

		Industry Rank	Sector Rank
Debt/Equity	0.73
Debt/FCF	N/A
Debt/EBITDA	2.44
Cap/Depr	113.3%
Cap/Sales	14.32%
Interest Coverage	250
Cash Conversion	59.68%
Profit Quality	N/A
Current Ratio	0.73
Quick Ratio	0.47
Altman-Z	0.75

F-Score6

WACC4.85%

ROIC/WACC0.34

Cap/Depr(3y)180.46%

Cap/Depr(5y)145.01%

Cap/Sales(3y)16.9%

Cap/Sales(5y)12.89%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-115.82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%1.17%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)23.65%

Revenue growth 3Y4.41%

Revenue growth 5YN/A

Sales Q2Q%21.02%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y227.92%

EBIT growth 3Y-10.46%

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y47.49%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-0.68%

OCF growth 3Y65.07%

OCF growth 5YN/A

FLORENTAISE SA / ALFLO.PA FAQ

Can you provide the ChartMill fundamental rating for FLORENTAISE SA?

ChartMill assigns a fundamental rating of 2 / 10 to ALFLO.PA.

Can you provide the valuation status for FLORENTAISE SA?

ChartMill assigns a valuation rating of 1 / 10 to FLORENTAISE SA (ALFLO.PA). This can be considered as Overvalued.

Can you provide the profitability details for FLORENTAISE SA?

FLORENTAISE SA (ALFLO.PA) has a profitability rating of 3 / 10.

How financially healthy is FLORENTAISE SA?

The financial health rating of FLORENTAISE SA (ALFLO.PA) is 1 / 10.

Is the dividend of FLORENTAISE SA sustainable?

The dividend rating of FLORENTAISE SA (ALFLO.PA) is 0 / 10 and the dividend payout ratio is -538.46%.

FLORENTAISE SA (ALFLO.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

FLORENTAISE SA / ALFLO.PA FAQ

Can you provide the ChartMill fundamental rating for FLORENTAISE SA?

Can you provide the valuation status for FLORENTAISE SA?

Can you provide the profitability details for FLORENTAISE SA?

How financially healthy is FLORENTAISE SA?

Is the dividend of FLORENTAISE SA sustainable?